Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
GondolaBio researches, develops and manufactures pharmaceutical products.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Navigantis empowers physicians to deliver uncompromised neurovascular care by creating a new frontier in surgical robotics.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Myra Vision develops a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Cormorant Asset Management has invested in 205 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cormorant Asset Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 23 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post-IPO Equity round. Cormorant Asset Management's total known invested capital is $20.8B.
Cormorant Asset Management's average investment size is $136.8M across its portfolio of 205 companies.
Recent Cormorant Asset Management portfolio additions include Rapport Therapeutics, Ventyx Biosciences, RayzeBio, Avidity Biosciences, Atia Vision. These companies were founded in 2020 or later.